A Safety Study of AZD4041 in Healthy Participants

Trial Identifier: D7460C00002
Sponsor: AstraZeneca
Collaborator:
Altasciences Company Inc.
NCTID:: NCT05233085
Start Date: December 2021
Primary Completion Date: June 2022
Study Completion Date: June 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
French (Canada) Translation

Trial Locations

Country Location
CA, QC Laval, QC, CA, h7v 4bc